RVL Pharmaceuticals PLC
- Company Reg D Offering
| RVL Pharmaceuticals PLC |
| Firm |
|
| Fund # | |
| CIK # | 0001739426 |
| Sale | 2023-08-18
(5.0 M Offered, 5.0 M Sold)
|
| Fund | |
| Phone | 9088091300 |
| Address | 400 Crossing Boulevard
Bridgewater, New Jersey 08807 |
| Source |
[EDGAR]
|
| Amount Raised ($M) |
|
|
| Company Details |
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction | |
| Form D Offering |
| Filed | 2023-08-31 (D) |
| Exemption | 506(b) |
| Duration | One year or less |
| Commission | $812,500 |
| Revenue | Decline to Disclose |
{"search": "/search", "clicked": "/clicked", "portfolio_add": "/portfolio-add", "portfolio_remove": "/portfolio-remove", "portfolio_create": "/portfolio-create", "portfolio_activate": "/portfolio-activate", "portfolio_delete": "/portfolio-delete", "portfolio_rename": "/portfolio-rename", "portfolio_color": "/portfolio-color", "home_filter": "/home-filter", "htmlspeed": "/htmlspeed", "add_tag_firm": "/add-tag-firm", "add_tag_click": "/add-tag-click", "copy_aum": "/copy-aum", "stripe_checkout": "/stripe-checkout", "stripe_subscribe": "/stripe-subscribe", "update_card": "/update-card"}
{"uid": 215726784, "pid": -1, "pid_a": [], "name": "", "email": "", "blacklist_f": false, "paywall_f": false, "paywall_n": 0, "random_n": 0}
False
322568047